Presentation TCT 2014 Use of OCT to Evaluate Stent Failures (Thrombosis and Restenosis) Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Evelyn S. Regar September 14, 2014
Presentation TCT 2014 TCT 479: The Increased Risk of Stent Thrombosis in Acute Coronary Syndromes Is Confined to the First 30 Days After PCI: Results from the Multicenter ADAPT-DES Study Presenter: Dietmar Trenk, Harvey D. White, Dominick J. Angiolillo, Ajay J. Kirtane September 14, 2014
Presentation TCT 2014 Use of IVUS to Evaluate Stent Failures (Thrombosis and Restenosis) Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Gary S. Mintz September 14, 2014
Presentation TCT 2014 Case Study: Recurrent Stent Thrombosis Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Tullio Palmerini September 14, 2014
Presentation TCT 2014 Hematologic Etiologies of Stent Thrombosis and How to Evaluate Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Giulio G. Stefanini September 14, 2014
Presentation TCT 2014 Evaluation and Treatment of Stent Thrombosis: From Acute Patency to Long-term Vascular Stability Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Ron Waksman September 14, 2014
Presentation TCT 2014 TCT 642: Stent Thrombosis Rates with an Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus a Durable Polymer, Everolimus-Eluting Stent in Patients Undergoing Percutaneous Coronary Intervention: 3-Year Follow-up from the COMPARE II Trial Presenter: Pieter C. Smits September 14, 2014
Presentation TCT 2014 TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial Presenter: Evald H. Christiansen September 14, 2014
Presentation TCT 2014 Follow the Data: Fluorinated Polymer-Based DES are Safer than Bioresorbable-Based DES! Presenter: Hyo-Soo Kim September 14, 2014
Presentation TCT 2014 Bioresorbable Polymer-Based DES are the Right Choice to Minimize Stent Thrombosis! Presenter: Stephan Windecker September 14, 2014
Presentation TCT 2014 Are Current DES Really Safer Than BMS? Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Tullio Palmerini September 14, 2014
Presentation TCT 2014 Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific? Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Marco Valgimigli September 14, 2014
Presentation TCT 2014 Prevention of Stent Thrombosis: Devices, Pharmacology, Technique, Patients, and More Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Lorenz Raber September 14, 2014
Presentation TCT 2014 TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results Presenter: Donald Cutlip, Manel Sabate, Elvin Kedhi, Lisette Okkels Jensen September 14, 2014
News Conference News TCT 2014 Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent September 14, 2014
News Conference News TCT 2014 EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion September 14, 2014
News Conference News TCT 2014 COMPARE II: STEMI Patients See Strong Results with Both BES and EES September 14, 2014
News Conference News TCT 2014 ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES Yael L. Maxwell September 14, 2014